The objective of this study is to evaluate the efficacy and safety of sotatercept treatment (plus background PAH therapy) versus placebo (plus background PAH therapy) at 24 weeks in adults with PAH.
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
University of Colorado Hospital
David Badesch, MD
Protocol Number: 20-2581
More information available at ClinicalTrials.gov: NCT04576988
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers